Virtual Symposium (Expired): New Developments in Insulin Therapy: Expert Insights in Individualizing Treatment

Despite well-established treatment guidelines, many patients with T2DM are not managed optimally and fail to achieve recommended levels of blood glucose control. Delays in initiating insulin, however, are common and may stem from both physician and patient barriers. Negative patient perceptions regarding insulin include complicated dosing regimens, fear of injections, and hypoglycemia. Clinician concerns include hypoglycemia, weight gain, and the misconception that elevated insulin increases cardiovascular risks.

This activity will bring clinicians up to date on the latest available and emerging options in basal insulin therapy, alone and in combination with other antidiabetic agents. To help clinicians address the unmet needs of patients in this area, expert faculty will discuss common barriers to the initiation of and adherence to insulin therapy as well as strategies to overcome these barriers, including how to help patients successfully utilize new insulin delivery systems and technology designed to make therapy simpler and more convenient.

Introduction and Case Presentation

Faculty: Bernard Zinman, MD

The Legacy Effect in Type 2 Diabetes: Rationale and Benefits for Achieving Early Glycemic Control

Faculty: Anne L. Peters, MD

Overcoming Barriers to Insulin Therapy: Strategies to Improve Acceptance and Adherence

Faculty: Jean-François Yale, MD, FRCPC

How Next-Generation Insulin Preparations and Novel Combinations Can Improve Patient Satisfaction and Address Cardiometabolic Risk

Faculty: Athena Philis-Tsimikas, MD

Panel Discussion: Case Study and Audience Q&A

Presenter: All Faculty